Karen M. Anderson, the Chief People Officer of $CNTA, sold 41,076 shares of the company on 03-26-2026 for an estimated $1,237,381. We received data on the trade from a recent SEC filing. This was a sale of approximately 39.8% of their shares of this class of stock. Following this trade, they now own 62,085 shares of this class of $CNTA stock.
$CNTA Insider Trading Activity
$CNTA insiders have traded $CNTA stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $CNTA stock by insiders over the last 6 months:
- KAREN M. ANDERSON (Chief People Officer) has made 0 purchases and 5 sales selling 235,916 shares for an estimated $6,497,233.
- GREGORY M WEINHOFF (Chief Business Officer) has made 0 purchases and 3 sales selling 97,194 shares for an estimated $2,647,071.
- TIA L BUSH (Chief Technology & Quality Ofc) has made 0 purchases and 2 sales selling 80,000 shares for an estimated $2,160,000.
- IQBAL J HUSSAIN (Chief Legal Officer) has made 0 purchases and 4 sales selling 51,961 shares for an estimated $1,305,191.
- MARIO ALBERTO ACCARDI (President, Orexin Program) has made 0 purchases and 4 sales selling 28,000 shares for an estimated $788,288.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CNTA Hedge Fund Activity
We have seen 89 institutional investors add shares of $CNTA stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AVORO CAPITAL ADVISORS LLC added 3,747,475 shares (+34.7%) to their portfolio in Q4 2025, for an estimated $93,724,349
- GENERAL ATLANTIC, L.P. removed 3,564,103 shares (-36.8%) from their portfolio in Q4 2025, for an estimated $89,138,216
- FMR LLC added 2,684,696 shares (+42.8%) to their portfolio in Q4 2025, for an estimated $67,144,246
- ECOR1 CAPITAL, LLC added 2,565,000 shares (+466.4%) to their portfolio in Q4 2025, for an estimated $64,150,650
- BRAIDWELL LP added 2,188,320 shares (+inf%) to their portfolio in Q4 2025, for an estimated $54,729,883
- DEEP TRACK CAPITAL, LP added 2,000,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $50,020,000
- COMMODORE CAPITAL LP removed 1,850,000 shares (-64.9%) from their portfolio in Q4 2025, for an estimated $46,268,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CNTA Analyst Ratings
Wall Street analysts have issued reports on $CNTA in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 01/08/2026
- Oppenheimer issued a "Outperform" rating on 12/10/2025
- B. Riley Securities issued a "Buy" rating on 12/01/2025
- Guggenheim issued a "Buy" rating on 11/18/2025
- Wells Fargo issued a "Overweight" rating on 11/13/2025
- Stephens & Co. issued a "Overweight" rating on 10/28/2025
To track analyst ratings and price targets for $CNTA, check out Quiver Quantitative's $CNTA forecast page.
$CNTA Price Targets
Multiple analysts have issued price targets for $CNTA recently. We have seen 8 analysts offer price targets for $CNTA in the last 6 months, with a median target of $39.0.
Here are some recent targets:
- Rudy Li from Wolfe Research set a target price of $40.0 on 02/24/2026
- Danielle Brill from Truist Securities set a target price of $38.0 on 01/29/2026
- Rudy Li from Chardan Capital set a target price of $30.0 on 01/02/2026
- Kostas Biliouris from Oppenheimer set a target price of $62.0 on 12/10/2025
- Mayank Mamtani from B. Riley Securities set a target price of $42.0 on 12/01/2025
- Debjit Chattopadhyay from Guggenheim set a target price of $43.0 on 11/18/2025
- Benjamin Burnett from Wells Fargo set a target price of $35.0 on 11/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
